Sponsor
David J. Taylor
Representative · R-OH
Representative · R-OH
The bill supplies HHS guidance and public reporting to improve clinical response to nitazene overdoses and enable oversight, but it does not fund implementation, so under‑resourced hospitals and rural EMS may struggle to realize those benefits quickly.
Emergency departments, hospitals, and EMS (including rural and volunteer crews) will have evidence-based, tailored clinical guidance and protocols (including naloxone use) for treating nitazene and other ultra‑potent synthetic opioid overdoses, improving emergency response and reducing fatalities.
Providers, local officials, and the public will get access to guidance on the HHS website and Congress will receive a report, increasing transparency, speeding local adoption of best practices, and enabling oversight or follow-up policy/funding decisions.
Hospitals, EDs, and EMS may incur costs to train staff or buy more naloxone because the guidance does not include federal funding for implementation.
Rural and volunteer EMS may lack the staffing, training, or logistical capacity to implement the recommendations quickly, limiting near‑term impact in underserved areas.
Based on analysis of 2 sections of legislative text.
Requires HHS to publish evidence-based clinical guidelines for nitazene/ultra‑potent opioid overdoses within 180 days and report to Congress within one year.
Official title: To direct the Secretary of Health and Human Services to issue guidelines for the purpose of addressing the problem of nitazene overdoses, and for other purposes.
Introduced April 2, 2026 by David J. Taylor · Last progress April 2, 2026
Requires HHS to create and publish evidence-based clinical guidelines for responding to nitazene overdoses — including naloxone best practices and tailored guidance for emergency departments, hospitals, and rural/volunteer EMS — within 180 days of enactment, and to send Congress a report describing the guidelines and how they will address nitazene overdoses within one year. The bill defines “nitazene” (a class of ultra‑potent benzimidazole opioids, with examples) and defines “nitazene overdose.”